M0300 HCPCS Level II code: Iv chelation therapy (chemical endarterectomy)
M0300 is the HCPCS code for “Iv chelation therapy (chemical endarterectomy)” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
M0300Iv chelation therapy (chemical endarterectomy)
Short description: Iv chelationtherapy
HCPCS · United States
Medicare details
The indicators CMS publishes with M0300 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Non-covered by Medicare
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Other - Non-Medicare fee schedule
- Added
- Jan 1, 1986
Where M0300 sits
- 1M codesMedical services and quality measures
- 2Active code M0300Iv chelation therapy (chemical endarterectomy)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code M0300 mean?
M0300 is the HCPCS code for “Iv chelation therapy (chemical endarterectomy)” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover M0300?
CMS lists M0300’s Medicare coverage as “Non-covered by Medicare” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside M0300
All M codesM0245Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoringM0246Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been…M0247Intravenous infusion, sotrovimab, includes infusion and post administration monitoringM0248Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made…M0249Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require…M0250Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require…M0301Fabric wrapping of abdominal aneurysmM1000Pain screened as moderate to severeM1001Plan of care to address moderate to severe pain documented on or before the date of the second visit with a clinicianM1002Plan of care for moderate to severe pain not documented on or before the date of the second visit with a clinician, reason not givenM1003Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapyM1004Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently…